
Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.
Long-acting B-agonist (LABA) monotherapy among patients with asthma is rare. Of those with continued LABA monotherapy, most had missed opportunities for therapy change or education.
Published: April 14th 2011 | Updated:
Published: December 1st 2005 | Updated:
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831
© 2025 MJH Life Sciences®
All rights reserved.